Parliament Workbench
Data: Motions & questions to 26 Nov 2026

Written Question · S5W-23920 · Session 5

In light of the most recent Detect Cancer Early Programme Staging Data, which was published on 31 July 2018, what measures it is taking to …

Answered Asked by Brian Whittle Con Lodged 19 Jun 2019

The question

To ask the Scottish Government, in light of the most recent Detect Cancer Early Programme Staging Data, which was published on 31 July 2018, what measures it is taking to improve early stage lung cancer diagnosis in the most deprived areas.

The answer

Answered by Jeane Freeman on 9 Jul 2019 · 20 days after it was lodged, on time

Our commitment to early detection is reflected in our £42 million Detect Cancer Early (DCE) Programme that aims to increase the proportion of breast, bowel and lung cancers diagnosed early in Scotland. The Programme also aims to reduce the inequality gap as those from more deprived areas are less likely to take part in screening and are more likely to present at a later stage, when the chance of survival is lower.
Social marketing has a key role to play in the early detection of lung cancer, targeting those from areas of deprivation. Sir Alex Ferguson has fronted DCE’s marketing activity since 2013 to raise awareness of the benefits of early detection, while reminding people that lung cancer is no longer a death sentence. This has contributed to the 31.0% increase in stage one lung diagnoses in the most deprived areas of Scotland since DCE began. A new social marketing approach is now being explored with key stakeholders and leading clinicians to ensure those at higher risk of lung cancer remain alert to possible signs and symptoms of lung cancer and feel empowered to act early. A new DCE roadshow will also be targeting areas of high deprivation across Scotland this summer, to reinforce messages around lung cancer survival direct to the public.
To support primary care clinicians in diagnosing cancer early, DCE funded a clinical refresh of the Scottish Referral Guidelines for Suspected Cancer, with updated evidence published January 2019. Eight pathways were included in the refresh, including lung. In collaboration with Cancer Research UK and Macmillan Cancer Support, work continues across NHSScotland to ensure the guidance is fully disseminated and adopted.
Meanwhile, the Scottish Government is currently exploring what opportunities exist for Scotland to contribute to the emerging evidence base of lung cancer screening for high risk individuals. Officials have recently met with academics, the Chair of the UK National Screening Committee, and the Scottish Screening Committee to discuss ongoing studies and trials, to identify where Scotland can best add value. These discussions are ongoing and any recommendations will be carefully considered.

In the Official Report

No contribution in the Official Report cites S5W-23920 by reference.